Skip to main content
Log in

Metallothionein-like proteins and cell resistance tocis-dichlorodiammineplatinum(II) in L1210 cells

  • Original Articles
  • Metallothionein, Resistance, cis-Platinum (II), L1210 Cells
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Our studies on the mechanism of resistance of the murine leukemia L1210-PDD line tocis-dichlorodiammineplatinum(II) (cis-DDP) have not shown why it is 10-fold more resistant to the drug than the L1210 line. For this reason we investigated metallothionein-like proteins (‘MTs’) in these cells. Soluble protein extracts from cultures treated for 24 h withcis-DDP, zinc sulphate or saline were anaerobically eluted from columns of chemically reduced Sephadex G-75, and the profiles of zinc, copper and platinum were determined along with those for incorporated radioactive cyst(e)ien and tyrosine. Both salinetreated cell lines contained similar levels of ‘MTs’, which were induced by exposure to a minimally toxic level of zinc (100 μM). Zinc induction of ‘MTs’ was nearly 4-fold greater in L1210 than in L1210-PDD cells. The levels of mRNA for metallothionein I (MTI) and (MTII) in uninduced cells were measured by dot-blotting with a cDNA probe. The L1210-PDD cells contained 80% of the MTI and 41% of the MTII compared with L1210 cells, confirming the similar levels in uninduced cells. L1210-PDD cells were 2-fold more sensitive than L1210 cells to cadmium and equally sensitive to zinc. Thus, the resistance of L1210-PDD cells tocis-DDP was not associated with cross-resistance to group IIb metals, whereas their sensitivity to cadmium did reflect the relative inability of the cells to synthesize ‘MTs’. The L1210 cells produced ‘MTs’ when treated with 0.5 and 5.0 μM cis-DDP, but the L1210-DDP cells did not when treated with 5.0–40 μM cis-DDP. Small amounts of platinum (<21% of the total eluted) were bound to ‘MTs’ in both cell lines, but platinum provided a minor portion of the ‘MT’-bound metals, with zinc and copper contributing the bulk. The basis for the resistance of L1210-PDD cell tocis-DDP is neither an increased level of ‘MTs’ in the resistant cells nor an enhanced ability to increase the synthesis of ‘MTs’ after drug exposure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alexander J, Forre O, Aaseth J, Dobloug J, Overbo S (1982) Induction of a metallothionein-like protein in human lymphocytes. Scand J Immunol 15:217

    Google Scholar 

  2. Arrich BA, Nathan CF (1984) Glutathione metabolism as a determinant of therapeutic efficacy. Cancer Res 44:4224

    Google Scholar 

  3. Bakka A, Endresen L, Johnsen ABS, Edminson PD, Rugstad HE (1981) Resistance againstcis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol 61:215

    Google Scholar 

  4. Bakka A, Johnsen AS, Endresen L, Rugstad HE (1982) Radio-resistance in cells with high content of metallothionein. Experientia 38:381

    Google Scholar 

  5. Basolo F, Pearson RG (1967). Mechanisms of inorganic reactions. A study of metal complexes in solution, 2nd edn. Wiley, New York

    Google Scholar 

  6. Batist G, Tulpules A, Sinha BK, Katki AG, Myers CE, Cowan KH (1986) Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261:5544

    Google Scholar 

  7. Beach LR, Palmiter RD (1981) Amplification of the metalothionein-K gene in cadmium-resistant mouse cells. Proc Natl Acad Sci USA 78:2110

    Google Scholar 

  8. Bertino JR, Cadman ED, Weiner HL, Cashmore A, Moroson BA, Srimatkandada S, Schornagel JH, Medina WD, Dube SK (1983) Gene amplification and altered enzymes as mechanisms for the development of drug resistance. Cancer Treat Rep 67:901

    Google Scholar 

  9. Burchenal JH, Kalaher K, Dew KL, Gale G (1979) Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivatives. Biochimie 60:961

    Google Scholar 

  10. Cole WC, Wolf W (1980) Preparation and metabolism of a cisplatin/serum protein complex. Chem-Biol Interact 30:223

    Google Scholar 

  11. Davis LG, Dibner MD, Battey JF (1986) Basic methods in molecular biology, ch 11-1. p 130, Elsevier, New York

    Google Scholar 

  12. Domin BA, Grill SP, Cheng Y (1983) Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy. Cancer Res 43:2155

    Google Scholar 

  13. Durnam DM, Palmiter RD (1984) Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: evidence for gratuitous inducers. Mol Cell Biol 4:484

    Google Scholar 

  14. Eastman A, Illenye S (1984) Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes. Cancer Treat Rep 68:1189

    Google Scholar 

  15. Endresen L, Bakka A, Rugstad HE (1983) Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res 43:2918

    Google Scholar 

  16. Evans RM, Patierno SR, Wang D-S, Cantoni O, Costa M (1983) Growth inhibition and metallothionein induction in cadmium-resistant cells by essential and non-essential metals. Mol Pharmacol 24:77

    Google Scholar 

  17. Farnworth PG, Hillcoat BL, Roos IAG (1989) Metallothionein induction in mouse tissues bycis-dichlorodiammineplatinum(II) and its hydrolysis products. Chem Biol Interact 69:319

    Google Scholar 

  18. Feinberg A, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6

    Google Scholar 

  19. Feinberg A, Vogelstein B (1984) Addendum: a technique for radiolabelling DNA restriction endonuclease fragments to a high specific activity. Anal Biochem 137:266

    Google Scholar 

  20. Gick GG, McCarty KS Sr (1982) Amplification of the metallothionein-I gene in cadmium- and zinc-resistant Chinese hamster ovary cells. J Biol Chem 257:9049

    Google Scholar 

  21. Glennas A, Bakka A, Rugstad HE (1983) Cultured human cells with a high content of metallothionein show resistance against gold chloride. Scand J Rheumatol 12:321

    Google Scholar 

  22. Goering PL, Klaassen CD (1984) Zinc-induced tolerance to cadmium hepatotoxicity. Toxicol Appl Pharmacol 74:299

    Google Scholar 

  23. Hayashi K, Fujiki H, Sugimura T (1983) Effects of tumor promoters on the frequency of metallothionein I gene amplification in cells exposed to cadmium. Cancer Res 43:5433

    Google Scholar 

  24. Hildebrand CE, Cram LS (1979) Distribution of cadmium in human blood cultured in low levels of CdCl2: accumulation of Cd in lymphocytes and preferential binding to metallothionein. Proc Soc Exp Biol Med 161:438

    Google Scholar 

  25. Hildebrand CE, Tobey RA, Campbell EW, Enger MD (1979) A cadmium-resistant variant of the Chinese hamster (CHO) cell with increased metallothionein induction capacity. Exp Cell Res 124:237

    Google Scholar 

  26. Hildebrand CE, Griffith JK, Tobey RA, Walters RA, Enger MD (1981) Morecular mechanisms of Cd detoxification in Cd-resistant cultured cells: role of metallothionein and other inducible factors. In: The biological role of metallothionein. Elsevier, Amsterdam, p 279

    Google Scholar 

  27. Howe-Grant ME, Lippard SJ (1980) Aqueous platinum(II) chemistry; binding to biological molecules. Metal Ions Biol Systems 11:63

    Google Scholar 

  28. Instruction manual (1987) Zeta-probe blotting membrane. Biorad, California.

    Google Scholar 

  29. Kagi JHR, Nordberg M (1979) Metallothionein. Experientia Supplement 34. Birkhäuser, Basel

    Google Scholar 

  30. Karin M, Andersen RD, Herschman HR (1980) Induction of metallothionein mRNA in HeLa cells by dexamethasone and by heavy metals. Eur J Biochem 118:527

    Google Scholar 

  31. Karin M, Haslinger A, Holtgreve H, Richards RI, Krauter P, Westphal HM, Bento M (1984) Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 308:513

    Google Scholar 

  32. Kobayashi S, Kimura M (1980) Different inducibility of metallothionein in various mammalian cells in vitro. Toxicol Lett 5:357

    Google Scholar 

  33. Kraker A, Schmidt J, Krezoski S, Petering DH (1985) Binding ofcis-dichlorodiammineplatinum(II) to metallothionein in Ehrlich cells. Biochem Biophys Res Commun 130:786

    Google Scholar 

  34. Litterst CL (1984) Cisplatinum: a review, with special reference to cellular and molecular interactions. Agents Actions 15:520

    Google Scholar 

  35. Lonnerdal B (1980) Chemical modification of dextran gels for gel filtration of trace element ligands. In: Trace element analytical chemistry in medicine and biology. Walter de Gruyter, Berlin, p 439

    Google Scholar 

  36. Martin RB (1983) Hydrolytic equilibria and N7 versus N1 binding in purine nucleosides ofcis-diamminedichloroplatinum(II). Palladium(II) as a guide to platinum(II) reactions at equilibrium. In: Lippard SJ (ed) Platinum, gold, and other metal chemotherapeutic agents. American Chemical Society, Washington, DC (ACS Symposium Series 209, p 231)

    Google Scholar 

  37. Mason R, Edwards IR, McLaren SJ (1984) Interaction of platinum with metallothionein-like ligands in the rat kidney after administration ofcis-dichlorodiammineplatinum(II). Chem Biol Interact 49:165

    Google Scholar 

  38. Murphy MP, Andrews PA, Howell SB (1985) Metallothionein mediated cisplatin and melphalan resistance in human ovarian carcinoma [Abstract 1357]. Proc Am Assoc Cancer 26:344

    Google Scholar 

  39. Naganuma A, Satoh M, Koyama Y, Imura N (1985) Protective effect of metallothionein inducing metals on lethal toxicity ofcis-diamminedichloroplatinum in mice. Toxicol Lett 24: 203

    Google Scholar 

  40. Panemangalore M, Brady FO (1978) Induction and synthesis of metallothionein in isolated perfused rat liver. J Biol Chem 253:7898

    Google Scholar 

  41. Riordan JR, Ling V (1986) Genetic and biochemical characterization of multidrug resistance. In: Membrane transport of antineoplastic agents. Pergamon, Oxford, p 215

    Google Scholar 

  42. Roberts JJ, Pera MF Jr (1983) DNA as a target for anticancer coordination compounds. In: Lippard SJ (ed) Platinum, gold, and other metal chemotherapeutic agents. American Chemical Society, Washington, DC (ACS Symposium Series 209, p 3)

    Google Scholar 

  43. Schimke RT, Beverley S, Brown P, Cassin R, Federspiel N, Gasser C, Hill A, Johnston R, Marian B, Masse E, Rath H, Smouse D, Ilsty T (1984) Gene amplification and drug resistance in cultured animal cells. Cancer Treat Rev 11 [Suppl A]:9

    Google Scholar 

  44. Sharma RP, Edwards IR (1983)cis-Platinum: subcellular distribution and binding to cytosolic ligands. Biochem Pharmacol 32:2665

    Google Scholar 

  45. Shworak NW, Snyder FF, Gedamu L (1983) Identification of a cadmium-binding protein from a cadmium-resistant variant of human lymphoblastoid cells (WI-L2). Biochim Biophys Acta 763:332

    Google Scholar 

  46. Sirotnak FM (1986) Correlates of folate analog transport. pharmacokinetics and selective antitumor action. In: Membrane transport of antineoplastic agents. Pergamon, Oxford, p 241

    Google Scholar 

  47. Stone F (1989) Studies on the resistance of murine leukemia cells to cisplatinum. PhD Thesis, submitted to the University of Melbourne

  48. Zelazowski AJ, Garvey JS, Hoeschele JD (1984) In vivo and in vitro binding of platinum to metallothionein. Arch Biochem Biophys 229:246

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was funded from a Peter Crimmins Research Fellowship held by P. G. F.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farnworth, P., Hillcoat, B. & Roos, I. Metallothionein-like proteins and cell resistance tocis-dichlorodiammineplatinum(II) in L1210 cells. Cancer Chemother. Pharmacol. 25, 411–417 (1990). https://doi.org/10.1007/BF00686051

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686051

Keywords

Navigation